compound, pharmaceutical composition, method for binding opioid receptors, method for treating gastrointestinal dysfunction, method for treating intestinal obstruction, method for treating an opioid side effect and method for treating pain
Novel 3,4-disubstituted-4-(3-carbamoylphenyl)-piperidinylpropanoic acid compounds and their salts, including pharmaceutically acceptable salts, pharmaceutical compositions and methods of their use are disclosed. The novel compounds are useful, inter alia, as antagonists of opioid receptors.
